Euclidean Capital Llc - Net Worth and Insider Trading
Euclidean Capital Llc Net Worth
The estimated net worth of Euclidean Capital Llc is at least $212,255 dollars as of 2024-11-13. Euclidean Capital Llc is the 10% Owner of PMV Pharmaceuticals Inc and owns about 127,099 shares of PMV Pharmaceuticals Inc (PMVP) stock worth over $212,255. Details can be seen in Euclidean Capital Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Euclidean Capital Llc has not made any transactions after 2021-06-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Euclidean Capital Llc
Euclidean Capital Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Euclidean Capital Llc owns 1 companies in total, including PMV Pharmaceuticals Inc (PMVP) .
Click here to see the complete history of Euclidean Capital Llc’s form 4 insider trades.
Insider Ownership Summary of Euclidean Capital Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PMVP | PMV Pharmaceuticals Inc | 2021-06-14 | 10 percent owner |
Euclidean Capital Llc Latest Holdings Summary
Euclidean Capital Llc currently owns a total of 1 stock. Euclidean Capital Llc owns 127,099 shares of PMV Pharmaceuticals Inc (PMVP) as of June 14, 2021, with a value of $212,255.
Latest Holdings of Euclidean Capital Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PMVP | PMV Pharmaceuticals Inc | 2021-06-14 | 127,099 | 1.67 | 212,255 |
Holding Weightings of Euclidean Capital Llc
Euclidean Capital Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Euclidean Capital Llc has made a total of 3 transactions in PMV Pharmaceuticals Inc (PMVP) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in PMV Pharmaceuticals Inc is the sale of 66,396 shares on June 14, 2021, which brought Euclidean Capital Llc around $2 Million.
Insider Trading History of Euclidean Capital Llc
- 1
Euclidean Capital Llc Trading Performance
Euclidean Capital Llc Ownership Network
Ownership Network List of Euclidean Capital Llc
Ownership Network Relation of Euclidean Capital Llc
Euclidean Capital Llc Owned Company Details
What does PMV Pharmaceuticals Inc do?
Who are the key executives at PMV Pharmaceuticals Inc?
Euclidean Capital Llc is the 10 percent owner of PMV Pharmaceuticals Inc. Other key executives at PMV Pharmaceuticals Inc include SVP & Regulatory Affairs and QA Deepika Jalota , 10 percent owner Orbimed Advisors Llc , and Chief Medical Officer Leila Alland .
PMV Pharmaceuticals Inc (PMVP) Insider Trades Summary
Over the past 18 months, Euclidean Capital Llc made no insider transaction in PMV Pharmaceuticals Inc (PMVP). Other recent insider transactions involving PMV Pharmaceuticals Inc (PMVP) include a net sale of 11,322 shares made by Deepika Jalota , a net sale of 87,786 shares made by Orbimed Advisors Llc , and a net sale of 6,291 shares made by Leila Alland .
In summary, during the past 3 months, insiders sold 10,109 shares of PMV Pharmaceuticals Inc (PMVP) in total and bought 0 shares, with a net sale of 10,109 shares. During the past 18 months, 108,290 shares of PMV Pharmaceuticals Inc (PMVP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 108,290 shares.
PMV Pharmaceuticals Inc (PMVP)'s detailed insider trading history can be found in Insider Trading Tracker table.
PMV Pharmaceuticals Inc Insider Transactions
Euclidean Capital Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Euclidean Capital Llc. You might contact Euclidean Capital Llc via mailing address: 160 Fifth Ave, 9th Fl, New York Ny 10010.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
